Purpose
Genotyping
Method(s)
Multiplex Polymerase Chain Reaction (PCR) and multiplex Allele Specific Primer Extension (ASPE)
Suggested CPT Code(s)
81226
New York State Approval Status

Approved

Turnaround Time

15 days

Test Includes
1 Oxycodone CYP2D6 Genotype Multiplex Polymerase Chain Reaction (PCR) and multiplex Allele Specific Primer Extension (ASPE)
2 Predicted Patient Phenotype Multiplex Polymerase Chain Reaction (PCR) and multiplex Allele Specific Primer Extension (ASPE)

Test Also Known As
Oxycodone genotype
Specimen Type
Blood
Requested Volume
10 mL
Minimum Volume
9 mL
Special Handling
Submit two (2) 5 mL Lavender top tubes (EDTA) of anticoagulated blood. IMPORTANT: Mandatory consent form must be signed by the patient and sent in with each sample.
Specimen Container
Lavender top tube (EDTA)

Additional Collection Instructions

Transport Temperature
Refrigerated
Light Protection
Not Required
Rejection Criteria
Received Room Temperature. Samples received without the mandatory consent form.

Rejection criteria pertain to clinical specimen submissions only.

Stability
Room Temperature: 3 day(s)
Refrigerated: 7 day(s)
Frozen (-20 °C): 28 day(s)
1 Oxycodone CYP2D6 Genotype Multiplex Polymerase Chain Reaction (PCR) and multiplex Allele Specific Primer Extension (ASPE)
2 Predicted Patient Phenotype Multiplex Polymerase Chain Reaction (PCR) and multiplex Allele Specific Primer Extension (ASPE)

Interface Map

LOINC® Information